ARCHIVES

Give New Investigators “Special Consideration,” Advisors Tell NCI

This article is from The Cancer Letter archive.

Vol. 28 No. 26 | June 28, 2002

Download PDF Visit The Full Archive

Related Articles

Stories On Proscar Cause Confusion In Prostate Cancer Prevention Trial

September 6, 1996

Clinical Research Programs Could Be Accredited, IOM Says.

April 20, 2001

House Committee Aims To Cut Markup On Office-Administered Cancer Drugs.

November 16, 2001

New Journal Examines Claims Of Proponents Of Alternative Medicine

October 24, 1997

BMS Execs Knew Of Flaws In ImClone Plan For C225 Prior To $2-Billion Licensing Deal

June 21, 2002

ImClone “Screwed Up,” CEO Waksal Tells Conference; Stock Plunges.

January 11, 2002